These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9566751)
21. Effects of Aroclors and individual PCB congeners on activation of the human androgen receptor in vitro. Schrader TJ; Cooke GM Reprod Toxicol; 2003; 17(1):15-23. PubMed ID: 12507654 [TBL] [Abstract][Full Text] [Related]
23. Phorbol ester causes ligand-independent activation of the androgen receptor. Darne C; Veyssiere G; Jean C Eur J Biochem; 1998 Sep; 256(3):541-9. PubMed ID: 9780230 [TBL] [Abstract][Full Text] [Related]
24. Human reporter gene assays: transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context. Simon S; Mueller SO Toxicology; 2006 Mar; 220(2-3):90-103. PubMed ID: 16413649 [TBL] [Abstract][Full Text] [Related]
25. The use of a DNA-binding domain replacement method for the detection of a potential TR3 orphan receptor response element in the mouse mammary tumor virus long terminal repeat. Lee HJ; Kokontis J; Wang KC; Chang C Biochem Biophys Res Commun; 1993 Jul; 194(1):97-103. PubMed ID: 8392847 [TBL] [Abstract][Full Text] [Related]
26. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer. Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046 [TBL] [Abstract][Full Text] [Related]
27. Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5' promoter region of the gene. Murtha P; Tindall DJ; Young CY Biochemistry; 1993 Jun; 32(25):6459-64. PubMed ID: 7686046 [TBL] [Abstract][Full Text] [Related]
28. Catalytic cleavage of the androgen receptor messenger RNA and functional inhibition of androgen receptor activity by a hammerhead ribozyme. Chen S; Song CS; Lavrovsky Y; Bi B; Vellanoweth R; Chatterjee B; Roy AK Mol Endocrinol; 1998 Oct; 12(10):1558-66. PubMed ID: 9773979 [TBL] [Abstract][Full Text] [Related]
29. Myosin VI is a modulator of androgen-dependent gene expression. Loikkanen I; Toljamo K; Hirvikoski P; Väisänen T; Paavonen TK; Vaarala MH Oncol Rep; 2009 Nov; 22(5):991-5. PubMed ID: 19787211 [TBL] [Abstract][Full Text] [Related]
30. Androgen regulation of parathyroid hormone-related peptide production in human prostate cancer cells. Pizzi H; Gladu J; Carpio L; Miao D; Goltzman D; Rabbani SA Endocrinology; 2003 Mar; 144(3):858-67. PubMed ID: 12586762 [TBL] [Abstract][Full Text] [Related]
31. Transcriptional up-regulation of the human androgen receptor by androgen in bone cells. Wiren KM; Zhang X; Chang C; Keenan E; Orwoll ES Endocrinology; 1997 Jun; 138(6):2291-300. PubMed ID: 9165014 [TBL] [Abstract][Full Text] [Related]
32. Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone. Kemppainen JA; Langley E; Wong CI; Bobseine K; Kelce WR; Wilson EM Mol Endocrinol; 1999 Mar; 13(3):440-54. PubMed ID: 10077001 [TBL] [Abstract][Full Text] [Related]
33. 11 beta-Hydroxysteroid dehydrogenase and tissue specificity of androgen action in human prostate cancer cell LNCaP. Pagé N; Warriar N; Govindan MV J Steroid Biochem Mol Biol; 1994 Jun; 49(2-3):173-81. PubMed ID: 8031714 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells. He D; Falany CN Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250 [TBL] [Abstract][Full Text] [Related]
35. Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter. Luo LY; Grass L; Diamandis EP Clin Chim Acta; 2003 Nov; 337(1-2):115-26. PubMed ID: 14568187 [TBL] [Abstract][Full Text] [Related]
36. Enhancement of androgen-dependent transcription and cell proliferation by tributyltin and triphenyltin in human prostate cancer cells. Yamabe Y; Hoshino A; Imura N; Suzuki T; Himeno S Toxicol Appl Pharmacol; 2000 Dec; 169(2):177-84. PubMed ID: 11097870 [TBL] [Abstract][Full Text] [Related]
37. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Culig Z; Hobisch A; Cronauer MV; Cato AC; Hittmair A; Radmayr C; Eberle J; Bartsch G; Klocker H Mol Endocrinol; 1993 Dec; 7(12):1541-50. PubMed ID: 8145761 [TBL] [Abstract][Full Text] [Related]
38. Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action. Ding D; Xu L; Menon M; Reddy GP; Barrack ER Prostate; 2005 Feb; 62(2):133-9. PubMed ID: 15389799 [TBL] [Abstract][Full Text] [Related]
39. Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor. Wang LG; Liu XM; Kreis W; Budman DR Biochem Pharmacol; 1998 May; 55(9):1427-33. PubMed ID: 10076535 [TBL] [Abstract][Full Text] [Related]
40. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. Tan J; Sharief Y; Hamil KG; Gregory CW; Zang DY; Sar M; Gumerlock PH; deVere White RW; Pretlow TG; Harris SE; Wilson EM; Mohler JL; French FS Mol Endocrinol; 1997 Apr; 11(4):450-9. PubMed ID: 9092797 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]